BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32716150)

  • 1. EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis.
    Wang M; Liu T; Hu X; Yin A; Liu J; Wang X
    Panminerva Med; 2020 Sep; 62(3):150-154. PubMed ID: 32716150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway.
    Liu T; Zhou W; Zhang F; Shi G; Teng H; Xiao J; Wang Y
    Mol Med Rep; 2014 Jul; 10(1):169-74. PubMed ID: 24806332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ100284 promotes invasion and migration of osteosarcoma cells by down-regulating PTEN and EMP1.
    Liu YD; Liu LP
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6540-6550. PubMed ID: 32633341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2.
    Cheng ZH; Luo C; Guo ZL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9267-9276. PubMed ID: 31773678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1.
    Guan H; Shang G; Cui Y; Liu J; Sun X; Cao W; Wang Y; Li Y
    J Cell Physiol; 2019 Jun; 234(6):8998-9007. PubMed ID: 30317613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3β promotes osteosarcoma invasion and migration via regulating PTEN and phosphorylation of focal adhesion kinase.
    Mai W; Kong L; Yu H; Bao J; Song C; Qu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33969873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRX2-mediated upregulation of MMP-9 and VEGF in a PI3K/AKT-dependent manner.
    Liu T; Zhou W; Cai B; Chu J; Shi G; Teng H; Xu J; Xiao J; Wang Y
    Mol Med Rep; 2015 Sep; 12(3):4346-4351. PubMed ID: 26062523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEX3C promotes osteosarcoma malignant progression through negatively regulating FGF14.
    Cao Y; Jiang F; Zhang S; Yang L; Sun Y
    J BUON; 2020; 25(3):1554-1561. PubMed ID: 32862604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRX1 hypomethylation in osteosarcoma metastasis.
    Lu J; Wang J
    Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
    Han Y; Zhao X; Sun Y; Sui Y; Liu J
    J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
    Dai J; Lu L; Kang L; Zhang J
    Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
    Shen A; Zhang Y; Yang H; Xu R; Huang G
    J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
    Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
    Sun G; Zhao G; Lu Y; Wang Y; Yang C
    Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells.
    Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W
    Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Nucleotide Polymorphism (rs1056629) in 3'-UTR of MMP-9 is Responsible for a Decreased Risk of Metastatic Osteosarcoma by Compromising its Interaction with microRNA-491-5p.
    Tian X; Zhang X
    Cell Physiol Biochem; 2016; 38(4):1415-24. PubMed ID: 27023472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
    Huang JF; Du WX; Chen JJ
    J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.